Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway*

Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway

(2011) V. De Preter et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment

(2011) Ingrid Arijs et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species

(2010) Matthew PG Barnett et al.   BMC IMMUNOLOGY

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

(2009) I. Arijs et al.   GUT

Gene expression patterns in experimental colitis in IL-10-deficient mice

(2009) Jonathan J. Hansen et al.   INFLAMMATORY BOWEL DISEASES

Low counts of Faecalibacterium prausnitzii in colitis microbiota

(2009) H. Sokol et al.   INFLAMMATORY BOWEL DISEASES

Butyrate-Induced Transcriptional Changes in Human Colonic Mucosa

(2009) Steven A. L. W. Vanhoutvin et al.   PLoS One

Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment

(2009) Ingrid Arijs et al.   PLoS One

Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker

(2008) S. Danese   DIGESTIVE AND LIVER DISEASE

Microbial Influences in Inflammatory Bowel Diseases

(2008) R. Balfour Sartor   GASTROENTEROLOGY

Pouchitis, Similar to Active Ulcerative Colitis, Is Associated with Impaired Butyrate Oxidation by Intestinal Mucosa

(2008) Vicky De Preter et al.   INFLAMMATORY BOWEL DISEASES